financetom
Business
financetom
/
Business
/
Etsy Faces 'More Balanced' Catalyst Path Driven by Core Gross Merchandise Sales Growth, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Etsy Faces 'More Balanced' Catalyst Path Driven by Core Gross Merchandise Sales Growth, Morgan Stanley Says
Jul 21, 2025 8:21 AM

11:05 AM EDT, 07/21/2025 (MT Newswires) -- Etsy's ( ETSY ) core gross merchandise sales growth is likely to re-accelerate in next year or two, potentially giving the company a "more balanced" catalyst path, Morgan Stanley said in a Sunday note.

The investment firm said it expects easing comps and a reduced tariff risk to boost the company's gross merchandise sales and accelerate revenue growth with continued take rate expansion. Etsy ( ETSY ) also faces a better macro environment and potential benefits from foreign exchange, Morgan Stanley added.

"We view increased spend per buyer or frequency as the primary path for ETSY ( ETSY ) to reach sustainable, profitable growth... but see frequency gains as highly difficult," Morgan Stanley said. The investment firm noted its ongoing concerns on Etsy's ( ETSY ) ability to drive frequency but said this is already factored into fiscal 2028 expectations.

Morgan Stanley upgraded Etsy ( ETSY ) to equal-weight from underweight, with a higher price target of $50 from $38.

Price: 60.33, Change: +0.69, Percent Change: +1.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck Says Pulmonary Arterial Hypertension Treatment Update Gets FDA Approval
Merck Says Pulmonary Arterial Hypertension Treatment Update Gets FDA Approval
Oct 27, 2025
07:25 AM EDT, 10/27/2025 (MT Newswires) -- Merck ( MRK ) said Monday it received approval for an update for Winrevair, a treatment for adults with pulmonary arterial hypertension, from the US Food and Drug Administration. The approval expands the indication of the drug to include components of clinical worsening events such as hospitalization, lung transplantation, and death, Merck (...
KPS CAPITAL PARTNERS TO ACQUIRE CONTROLLING STAKE IN KETJEN FROM ALBEMARLE
KPS CAPITAL PARTNERS TO ACQUIRE CONTROLLING STAKE IN KETJEN FROM ALBEMARLE
Oct 27, 2025
NEW COMPANY WILL BE A GLOBAL LEADER IN ADVANCED CATALYSTS AND ADDITIVES FOR THE REFINING AND PETROCHEMICAL INDUSTRIES NEW YORK, Oct. 27, 2025 /PRNewswire/ -- KPS Capital Partners, LP (KPS) announced today that, through a newly formed affiliate, it has entered into a definitive agreement with Albemarle Corporation ( ALB ) (Albemarle) to acquire a controlling stake in Ketjen...
Market Chatter: Barclays Re-Enters Saudi Arabia Market With New Office Planned Next Year
Market Chatter: Barclays Re-Enters Saudi Arabia Market With New Office Planned Next Year
Oct 27, 2025
07:23 AM EDT, 10/27/2025 (MT Newswires) -- Barclays ( BCS ) is re-entering the Saudi Arabian market with plans to open a new office in Riyadh next year, Bloomberg reported Monday, citing the company's Chief Executive C.S. Venkatakrishnan. The UK-based bank is in the process of obtaining a license to conduct investment banking activities in the country, he said during...
Buybacks take backseat as AI drives record US capex spending
Buybacks take backseat as AI drives record US capex spending
Oct 27, 2025
By Johann M Cherian (Reuters) -Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on. The priority for investors is long-term growth over immediate profits, recognizing that companies neglecting AI investment risk falling behind...
Copyright 2023-2026 - www.financetom.com All Rights Reserved